320 related articles for article (PubMed ID: 25162666)
21. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic evaluation and differential diagnosis of primary hyperparathyroidism].
Quesada Gómez JM
Endocrinol Nutr; 2009 Apr; 56 Suppl 1():14-9. PubMed ID: 19627756
[TBL] [Abstract][Full Text] [Related]
23. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
Majid H; Khan AH; Riaz M; Karimi H; Talati J
Endocr Pract; 2016 Jul; 22(7):814-21. PubMed ID: 27018622
[TBL] [Abstract][Full Text] [Related]
24. Hyperparathyroidism: primary or secondary disease?
Cordellat IM
Reumatol Clin; 2012; 8(5):287-91. PubMed ID: 22089066
[TBL] [Abstract][Full Text] [Related]
25. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
[TBL] [Abstract][Full Text] [Related]
26. Primary Hyperparathyroidism.
Masi L
Front Horm Res; 2019; 51():1-12. PubMed ID: 30641515
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
28. Normocalcemic Hyperparathyroidism.
Corbetta S
Front Horm Res; 2019; 51():23-39. PubMed ID: 30641527
[TBL] [Abstract][Full Text] [Related]
29. Clinical management of primary hyperparathyroidism and thresholds for surgical referral: a national study examining concordance between practice patterns and consensus panel recommendations.
Mahadevia PJ; Sosa JA; Levine MA; Zeiger MA; Powe NR
Endocr Pract; 2003; 9(6):494-503. PubMed ID: 14715476
[TBL] [Abstract][Full Text] [Related]
30. MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects.
Verdelli C; Corbetta S
Eur J Endocrinol; 2017 Jan; 176(1):R39-R52. PubMed ID: 27601015
[TBL] [Abstract][Full Text] [Related]
31. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
32. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
33. Normocalcemic primary hyperparathyroidism.
Cusano NE; Silverberg SJ; Bilezikian JP
J Clin Densitom; 2013; 16(1):33-9. PubMed ID: 23374739
[TBL] [Abstract][Full Text] [Related]
34. Medical management of primary hyperparathyroidism.
Khan AA
J Clin Densitom; 2013; 16(1):60-3. PubMed ID: 23374743
[TBL] [Abstract][Full Text] [Related]
35. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
Shinall MC; Dahir KM; Broome JT
Endocr Pract; 2013; 19(4):697-702. PubMed ID: 23425644
[TBL] [Abstract][Full Text] [Related]
36. Primary hyperparathyroidism.
Muñoz-Torres M; García-Martín A
Med Clin (Barc); 2018 Mar; 150(6):226-232. PubMed ID: 28992983
[TBL] [Abstract][Full Text] [Related]
37. Primary hyperparathyroidism.
Silva BC; Cusano NE; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):593-607. PubMed ID: 30449543
[TBL] [Abstract][Full Text] [Related]
38. How to manage an isolated elevated PTH?
Souberbielle JC; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2015 May; 76(2):134-41. PubMed ID: 25882890
[TBL] [Abstract][Full Text] [Related]
39. Asymptomatic primary hyperparathyroidism.
Silverberg SJ; Walker MD; Bilezikian JP
J Clin Densitom; 2013; 16(1):14-21. PubMed ID: 23374736
[TBL] [Abstract][Full Text] [Related]
40. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients.
Souberbielle JC; Massart C; Brailly-Tabard S; Cormier C; Cavalier E; Delanaye P; Chanson P
Eur J Endocrinol; 2016 Mar; 174(3):315-23. PubMed ID: 26628583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]